PIK3CD and neoplasm: MiR34a was reduced in NSCLC cells, and increased miR34a induced upregulation of PTEN and YY1, inhibition of CDK6 and inactivation of the PI3K/AKT pathway, thereby impeding tumor cell growth (49).